Key result
Endothelium-derived relaxing factor (EDRF) released from artery and vein possesses identical biological and chemical properties as nitric oxide, including a half-life of 3-5 seconds.
Population
Perfused bovine intrapulmonary artery and vein, and freshly isolated aortic endothelial cells
Comparison
Endothelium-derived relaxing factor released… vs Nitric oxide (NO) delivered by superfusion
Design
Preclinical
Authors
Loading...
Supports NO as EDRF in vessels; leaves open translation to human endothelial therapies.
This foundational preclinical study demonstrates that endothelium-derived relaxing factor (EDRF) is chemically and biologically identical to nitric oxide (NO).
Ignarro et al. (1987) studied Vascular smooth muscle relaxation. Endothelium-derived relaxing factor (EDRF) vs. Nitric oxide (NO) was evaluated on Biological and chemical properties (lability, cyclic GMP accumulation, and chemical identification). Endothelium-derived relaxing factor (EDRF) released from artery and vein possesses identical biological and chemical properties as nitric oxide, including a half-life of 3-5 seconds.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: